SLXNW (STOCKS)
Silexion Therapeutics Corp Warrant
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 14
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $89.00K |
| Benefits Costs and Expenses | $9.33M |
| Costs And Expenses | $9.33M |
| Nonoperating Income/Loss | $117.00K |
| Operating Expenses | $9.13M |
| Research and Development | $4.64M |
| Other Operating Expenses | $4.49M |
| Operating Income/Loss | -$9.13M |
| Income/Loss From Continuing Operations After Tax | -$9.25M |
| Income/Loss From Continuing Operations Before Tax | -$9.24M |
| Income Tax Expense/Benefit | $4.00K |
| Interest And Dividend Income, Operating | $89.00K |
| Net Income/Loss | -$9.25M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.25M |
| Net Income/Loss Available To Common Stockholders, Basic | $9.25M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$18.49M |
| Preferred Stock Dividends And Other Adjustments | -$18.49M |
| Basic Earnings Per Share | -$718.13 |
| Diluted Earnings Per Share | -$718.13 |
| Basic Average Shares | 1,328,263 |
| Diluted Average Shares | 1,328,263 |
| Assets | $11.61M |
| Current Assets | $11.06M |
| Prepaid Expenses | $1.74M |
| Other Current Assets | $9.32M |
| Noncurrent Assets | $559.00K |
| Fixed Assets | $26.00K |
| Other Non-current Assets | $533.00K |
| Liabilities | $4.64M |
| Current Liabilities | $2.79M |
| Accounts Payable | $946.00K |
| Wages | $721.00K |
| Other Current Liabilities | $1.12M |
| Noncurrent Liabilities | $1.85M |
| Equity | $6.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.98M |
| Liabilities And Equity | $11.61M |
| Net Cash Flow From Operating Activities | -$10.73M |
| Net Cash Flow From Operating Activities, Continuing | -$10.73M |
| Net Cash Flow From Investing Activities | -$5.79M |
| Net Cash Flow From Investing Activities, Continuing | -$5.79M |
| Net Cash Flow From Financing Activities | $15.77M |
| Net Cash Flow From Financing Activities, Continuing | $15.78M |
| Exchange Gains/Losses | -$8.00K |
| Net Cash Flow | $7.30M |
| Net Cash Flow, Continuing | $7.31M |
| Comprehensive Income/Loss | -$9.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.32M |
| Other Comprehensive Income/Loss | $0.00 |